• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidence and prevalence of pulmonary arterial hypertension in Germany.

作者信息

Hoeper Marius M, Huscher Doerte, Pittrow David

机构信息

Department of Respiratory Medicine, German Center of Lung Research (DZL), Hannover Medical School, Hannover, Germany.

Department of Rheumatology and Clinical Immunology, Charité University Hospital, and Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany.

出版信息

Int J Cardiol. 2016 Jan 15;203:612-3. doi: 10.1016/j.ijcard.2015.11.001. Epub 2015 Nov 9.

DOI:10.1016/j.ijcard.2015.11.001
PMID:26580339
Abstract
摘要

相似文献

1
Incidence and prevalence of pulmonary arterial hypertension in Germany.德国肺动脉高压的发病率和患病率。
Int J Cardiol. 2016 Jan 15;203:612-3. doi: 10.1016/j.ijcard.2015.11.001. Epub 2015 Nov 9.
2
Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study.荷兰系统性硬化症及其肺部并发症：一项流行病学研究。
Ann Rheum Dis. 2009 Jun;68(6):961-5. doi: 10.1136/ard.2008.091710. Epub 2008 May 29.
3
[Female gender and pulmonary arterial hypertension: a complex relationship].[女性性别与肺动脉高压：一种复杂的关系]
G Ital Cardiol (Rome). 2012 Jun;13(6):448-60. doi: 10.1714/1073.11764.
4
[Dyspnoea in Patients with Pulmonary Hypertension (PH) - a Survey in Spezialized German PH Centres].[肺动脉高压（PH）患者的呼吸困难——德国专业PH中心的一项调查]
Pneumologie. 2015 Jun;69(6):361-5. doi: 10.1055/s-0034-1391893. Epub 2015 Apr 21.
5
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.美国肺动脉高压患者的变化情况：REVEAL 与历史和非美国当代注册研究的不同之处。
Chest. 2011 Jan;139(1):128-37. doi: 10.1378/chest.10-0075. Epub 2010 Jun 17.
6
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.与芬氟拉明暴露相关的肺动脉高压：109例报告。
Eur Respir J. 2008 Feb;31(2):343-8. doi: 10.1183/09031936.00104807. Epub 2007 Oct 24.
7
An epidemiological study of pulmonary arterial hypertension.肺动脉高压的流行病学研究。
Eur Respir J. 2007 Jul;30(1):104-9. doi: 10.1183/09031936.00092306. Epub 2007 Mar 14.
8
Autoimmunity and pulmonary hypertension: a perspective.自身免疫与肺动脉高压：一种观点
Eur Respir J. 2005 Dec;26(6):1110-8. doi: 10.1183/09031936.05.00045705.
9
Pulmonary arterial hypertension in France: results from a national registry.法国肺动脉高压：一项全国性登记研究的结果
Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30. doi: 10.1164/rccm.200510-1668OC. Epub 2006 Feb 2.
10
Scope of problem of pulmonary arterial hypertension.肺动脉高压的问题范围。
Am J Med. 2015 Aug;128(8):844-51. doi: 10.1016/j.amjmed.2015.03.007. Epub 2015 Mar 27.

引用本文的文献

1
Pulmonary Hypertension: Let's Take Stock!肺动脉高压：让我们总结一下！
Life (Basel). 2025 Jul 18;15(7):1137. doi: 10.3390/life15071137.
2
Circulating biomarkers in pulmonary arterial hypertension: State-of-the-art review and future directions.肺动脉高压中的循环生物标志物：最新综述与未来方向
JHLT Open. 2024 Aug 23;6:100152. doi: 10.1016/j.jhlto.2024.100152. eCollection 2024 Nov.
3
Portopulmonary hypertension: Current developments and future perspectives.门肺高压：当前进展与未来展望
Liver Res. 2022 Mar 3;6(1):10-20. doi: 10.1016/j.livres.2022.02.002. eCollection 2022 Mar.
4
Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.1990-2021年全球、区域和国家肺动脉高压负担：全球疾病负担研究2021的系统分析
Lancet Respir Med. 2025 Jan;13(1):69-79. doi: 10.1016/S2213-2600(24)00295-9. Epub 2024 Oct 18.
5
Pulmonary Arterial Hypertension and TGF-β Superfamily Signaling: Focus on Sotatercept.肺动脉高压与 TGF-β 超家族信号通路：聚焦索他拉特塞。
BioDrugs. 2024 Nov;38(6):743-753. doi: 10.1007/s40259-024-00680-3. Epub 2024 Sep 18.
6
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real-world Evidence Working Group.推进肺动脉高压知识的真实世界证据：现状、挑战与机遇。肺血管研究所创新药物开发倡议真实世界证据工作组的共识声明。
Pulm Circ. 2023 Dec 21;13(4):e12317. doi: 10.1002/pul2.12317. eCollection 2023 Oct.
7
Sex-biased TGFβ signalling in pulmonary arterial hypertension.肺动脉高压中的性别偏倚 TGFβ 信号传导。
Cardiovasc Res. 2023 Oct 24;119(13):2262-2277. doi: 10.1093/cvr/cvad129.
8
Health Care Disparities in Pulmonary Arterial Hypertension.肺动脉高压中的医疗保健差异。
Clin Chest Med. 2023 Sep;44(3):543-554. doi: 10.1016/j.ccm.2023.03.010. Epub 2023 May 23.
9
Macitentan treatment of portopulmonary hypertension with hepatopulmonary syndrome: a case report and literature review.马西替坦治疗肝肺综合征合并门脉性肺动脉高压：病例报告及文献复习。
ESC Heart Fail. 2023 Aug;10(4):2718-2721. doi: 10.1002/ehf2.14431. Epub 2023 Jun 14.
10
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension.合并症对肺动脉高压初始联合治疗的相关性
ERJ Open Res. 2022 Nov 7;8(4). doi: 10.1183/23120541.00298-2022. eCollection 2022 Oct.